From: Nonsteroidal anti-inflammatory drug exposure and the risk of microscopic colitis
 | Total (%) | New MC (%) | MC Registry (%) | p-vala | All MC (%) | No MC (%) | p-valb |
---|---|---|---|---|---|---|---|
Number of patients | 198 | 21 (10.61) | 59 (29.80) | Â | 80 (40.40) | 118 (59.60) | Â |
Female | 140Â (70.71) | 16 (76.19) | 49 (83.05) | 0.49 | 65 (81.25) | 78 (66.10) | 0.01 |
Race/ethnicity | Â | Â | Â | Â | Â | Â | Â |
Caucasian | 179 (90.140) | 18 (85.71) | 57 (96.61) | 0.14 | 75 (93.75) | 104 (88.14) | 0.24 |
Hispanic | 5 (2.53) | 2 (9.52) | 1 (1.69) | 3 (3.75) | 2 (1.63) | ||
African American | 4 (2.02) | 0 (0.00) | 1 (1.69) | 1 (1.25) | 3 (2.54) | ||
Asian | 4 (2.02) | 0 (0.00) | 0 (0.00) | 0 (0.00) | 4 (3.25) | ||
Other/unknown | 6 (3.03) | 1 (4.76) | 0 (0.00) | 1 (1.25) | 5 (4.07) | ||
Age (years), Mean ± Standard deviation | 57.55 ± 15.27 | 59.05 ± 15.04 | 60.86 ± 14.42 | 0.63 | 60.38 ± 14.51 | 55.62 ± 15.53 | 0.03 |
Smoking status | Â | Â | Â | Â | Â | Â | Â |
Current | 20 (10.10) | 2 (9.52) | 10 (16.95) | 0.70 | 12 (15.00) | 8 (6.78) | 0.13 |
Former | 68 (34.34) | 8 (38.10) | 22 (37.29) | 30 (37.50) | 38 (32.20) | ||
Never | 109 (55.05) | 11 (52.38) | 27 (45.76) | 38 (47.50) | 71 (60.20) | ||
History of celiac disease | 2 (1.01) | 0 (0.00) | 1 (1.69) | 1.00 | 1 (1.22) | 1 (0.85) | 0.78 |
Diagnosis | Â | Â | Â | Â | Â | Â | Â |
Collagenous colitis |  | 6 (28.57) | 14 (23.73) | 0.66 | 20 (25.00) | – | – |
Lymphocytic colitis |  | 15 (71.43) | 45 (76.27) | 60 (75.00) | – |